Dr. Joshua Tierney, MD, Commended for His Dedication to Patient Care Before and After Surgical Procedures

3 years ago

Fort Collins, April 04, 2022 (GLOBE NEWSWIRE) -- Dr. Tierney is an award-winning, published, and fellowship-trained surgeon. Operating out of…

Dr. Brian Harkins Becomes the First Person to Use New AirSeal Abdomen Surgical Technology: Lowering Air Pressure in Cavities

3 years ago

Tomball, April 04, 2022 (GLOBE NEWSWIRE) -- A leading surgeon based in Tomball, Texas, has become the first person to…

Castellum, Inc. Announces $950,000 New Revolving Credit Facility from Live Oak Bank

3 years ago

Castellum, Inc. Announces $950,000 New Revolving Credit Facility from Live Oak Bank Castellum, Inc. (OTC: ONOV) announces that it has…

INmune Bio, Inc. Highlights INKmune™ Data Featured in NK Cells in Solid Tumors Workshop at Innate Killer Summit

3 years ago

INKmune™, unlike IL15 and other NK-activating cytokines, upregulates all mitochondrial survival proteins and more than 40 nutrient receptors on the…

Allied Corp Commends Colombian Government for Announcing the Final Approval of the Regulations for the Export of Cannabis From Colombia

3 years ago

KELOWNA, British Columbia, April 04, 2022 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to…

Dyadic International to Present at Upcoming Scientific Medical Meetings

3 years ago

JUPITER, Fla., April 04, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI) a global biotechnology…

Zealand Pharma to Participate in 21st Annual Needham Virtual Healthcare Conference

3 years ago

Company announcement – No. 11 / 2022 Zealand Pharma to Participate in 21st Annual Needham Virtual Healthcare Conference Copenhagen, DK and Boston, MA,…

Vaxcyte Doses First Participants in Phase 2 Portion of Ongoing VAX-24 Phase 1/2 Clinical Proof-of-Concept Study in Adults

3 years ago

-- Following Prespecified Review of Phase 1 Safety and Tolerability Data, Independent Data Monitoring Committee Recommends Study Proceed as Planned…

eFFECTOR Therapeutics Announces Transition in Clinical Leadership

3 years ago

Premal Patel, M.D., Ph.D., chief medical officer, has resigned to pursue a new career opportunity Robert Sikorski, M.D., Ph.D., to…

eGenesis Appoints Eliezer Katz, M.D., FACS, as Chief Medical Officer

3 years ago

CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- eGenesis, a gene-editing and genome-engineering company developing human-compatible organs and cells, today…